Cantab Biopharmaceuticals

Cantab Biopharmaceuticals Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in the discovery and development of biosuperior protein therapeutics. Founded in 2006, the company operates within the vibrant Cambridge Science Park, a prominent hub for biotechnology in Europe. Cantab focuses on enhancing previously marketed, off-patent biologics by employing advanced technologies in protein expression and engineering, process development, and manufacturing. The company's work aims to improve critical drug characteristics such as product presentation, stability, pharmacokinetics, pharmacodynamics, immunogenicity, and drug delivery. Through its extensive experience in biopharmaceutical discovery and good manufacturing practices (GMP), Cantab seeks to expedite the development of innovative therapies targeting hematology and infectious diseases.